PHIO
Phio Pharmaceuticals Corp.
Company overview
- Market capitalization
- $11.73M
- Employees
- 6
- Latest publication
- 2026-09-29
About Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States. It develops PH-762, an INTASYL compound designed to reduce the expression of PD-1 in multi-center Phase 1b dose-escalating clinical trials; PH-894, an INTASYL compound that is designed to specifically silence BRD4, a protein that controls gene expression in both T cells and tumor cells in preclinical studies. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was founded in 2003 and is based in King Of Prussia, Pennsylvania.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 70,000USD | 0USD | 0USD |
| Cost Of Revenue | 1,000USD | 1,000USD | 2,000USD | 1,074,000USD | — | 35,000USD | 644,000USD | 866,000USD |
| Gross Profit | -1,000USD | -1,000USD | -2,000USD | -1,074,000USD | — | 35,000USD | -644,000USD | -866,000USD |
| Research Development | 2,793,000USD | 1,477,000USD | 1,181,000USD | 1,074,000USD | 886,000USD | 985,000USD | 644,000USD | 866,000USD |
| Selling General Administrative | 1,374,000USD | 1,057,000USD | 1,324,000USD | 1,235,000USD | 986,000USD | 689,000USD | 946,000USD | 1,048,000USD |
| Total Operating Expenses | 4,167,000USD | 2,534,000USD | 2,505,000USD | 1,235,000USD | 1,872,000USD | 1,674,000USD | 946,000USD | 1,048,000USD |
| Operating Income | -4,167,000USD | -2,534,000USD | -2,505,000USD | -2,309,000USD | -1,872,000USD | -1,674,000USD | -1,590,000USD | -1,914,000USD |
| Interest Income | 161,000USD | — | — | — | 125,000USD | — | — | — |
| Net Interest Income | 161,000USD | 163,000USD | 113,000USD | — | 125,000USD | — | 66,000USD | — |
| Income Before Tax | -4,003,000USD | -2,371,000USD | -2,392,000USD | -2,166,000USD | -1,769,000USD | -1,626,000USD | -1,524,000USD | -1,846,000USD |
| Net Income | -4,003,000USD | -2,371,000USD | -2,392,000USD | -2,166,000USD | -1,769,000USD | -1,626,000USD | -1,524,000USD | -1,846,000USD |
| Net Income From Continuing Ops | -4,003,000USD | -2,371,000USD | -2,392,000USD | -2,166,000USD | -1,769,000USD | -1,626,000USD | -1,524,000USD | -1,846,000USD |
| Ebit | -4,167,000USD | -2,534,000USD | -2,505,000USD | -2,309,000USD | — | -1,639,000USD | -1,590,000USD | -1,914,000USD |
| Ebitda | -4,166,000USD | -2,533,000USD | -2,503,000USD | -2,308,500USD | -1,769,000USD | -1,626,000USD | -1,590,000USD | -1,913,000USD |
| Depreciation And Amortization | 1,000USD | 1,000USD | 2,000USD | 500USD | — | -35,000USD | 35,000USD | 1,000USD |
| Reconciled Depreciation | 1,000USD | 1,000USD | 2,000USD | 0USD | 0USD | 0USD | 0USD | 1,000USD |
| Total Other Income Expense Net | 164,000USD | 163,000USD | 113,000USD | 143,000USD | 103,000USD | 48,000USD | 66,000USD | 68,000USD |
| Interest Expense | — | — | 113,000USD | — | — | — | — | — |
| Unclassified Operating Expenses | — | — | — | -1,074,000USD | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | 9,276USD | — | — |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 1,001USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 4,362USD | 21,000USD | 138,000USD |
| Cost Of Revenue | 3,000USD | 3,643,000USD | 6,332,000USD | 193,000USD | 192,000USD | 3,716,000USD | 4,300,000USD | 4,326,000USD |
| Gross Profit | -3,000USD | -3,643,000USD | -6,332,000USD | -193,000USD | -192,000USD | -3,716,000USD | 21,000USD | 138,000USD |
| Research Development | 4,618,000USD | 3,643,000USD | 6,332,000USD | 7,012,000USD | 8,886,000USD | 3,716,000USD | 4,300,000USD | 4,326,000USD |
| Selling General Administrative | 4,602,000USD | 3,744,000USD | 4,288,000USD | 4,450,000USD | 4,625,000USD | 5,077,000USD | 4,708,000USD | 3,176,000USD |
| Total Operating Expenses | 9,220,000USD | 3,744,000USD | 4,492,000USD | 11,462,000USD | 13,511,000USD | 5,077,000USD | 9,008,000USD | 7,502,000USD |
| Operating Income | -9,220,000USD | -7,387,000USD | -10,824,000USD | -11,462,000USD | -13,511,000USD | -8,793,000USD | -8,987,000USD | -7,364,000USD |
| Net Interest Income | 520,000USD | 231,000USD | -8,000USD | — | -9,000USD | -1,000USD | — | — |
| Income Before Tax | -8,698,000USD | -7,150,000USD | -10,826,000USD | -11,480,000USD | -13,287,000USD | -8,794,000USD | -8,908,000USD | -7,360,000USD |
| Net Income | -8,698,000USD | -7,150,000USD | -10,826,000USD | -11,305,000USD | -13,212,000USD | -8,794,000USD | -8,841,000USD | -7,360,000USD |
| Net Income From Continuing Ops | -8,698,000USD | -7,150,000USD | -11,662,000USD | -11,480,000USD | -13,287,000USD | -8,794,000USD | -8,908,000USD | -7,360,000USD |
| Ebit | -9,220,000USD | -7,387,000USD | -10,826,000USD | -11,462,000USD | -13,511,000USD | -8,793,000USD | -8,987,000USD | -7,364,000USD |
| Ebitda | -9,217,000USD | -7,385,000USD | -10,642,000USD | -11,269,000USD | -13,436,000USD | -8,721,000USD | -8,920,000USD | -7,283,000USD |
| Depreciation And Amortization | 3,000USD | 2,000USD | 184,000USD | 193,000USD | 75,000USD | 72,000USD | 67,000USD | 81,000USD |
| Reconciled Depreciation | 3,000USD | 35,000USD | 187,000USD | 193,000USD | 75,000USD | 72,000USD | 67,000USD | 81,000USD |
| Total Other Income Expense Net | 522,000USD | 237,000USD | -2,000USD | -18,000USD | 224,000USD | -1,000USD | 79,000USD | 4,000USD |
| Unclassified Operating Expenses | — | -3,643,000USD | -6,128,000USD | — | — | -3,716,000USD | — | — |
| Interest Expense | — | 231,000USD | — | 175,000USD | 9,000USD | 0USD | 0USD | 0USD |
| Income Tax Expense | — | -7,150,000USD | 204,000USD | -175,000USD | -75,000USD | -134,297USD | -67,000USD | 4,000USD |
| Tax Provision | — | — | — | 0USD | 0USD | 0USD | 0USD | 0USD |
| Net Income Applicable To Common Shares | — | — | — | — | -13,287,000USD | -8,794,000USD | -8,908,000USD | -7,360,000USD |
| Non Operating Income Net Other | — | — | — | — | — | — | — | 4,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 14,307,000USD | 17,412,000USD | 21,487,000USD | 11,505,000USD | 11,301,000USD | 13,440,000USD | 5,738,000USD | 5,865,000USD |
| Cash And Equivalents | 12,996,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 14,298,000USD | 17,402,000USD | 21,476,000USD | 11,493,000USD | 11,294,000USD | 13,436,000USD | 5,736,000USD | 5,864,000USD |
| Other Current Assets | 1,302,000USD | 371,000USD | 445,000USD | 788,000USD | 519,000USD | 158,000USD | 354,000USD | 474,000USD |
| Total Liabilities | 1,705,000USD | — | — | — | — | — | — | — |
| Other Current Liabilities | 804,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 12,602,000USD | 16,462,000USD | 20,147,000USD | 9,839,000USD | 10,095,000USD | 12,170,000USD | 4,723,000USD | 4,946,000USD |
| Total Equity Including Noncontrolling Interest | 12,602,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 9,000USD | 10,000USD | 11,000USD | 12,000USD | 7,000USD | 4,000USD | 2,000USD | 1,000USD |
| Accounts Payable | 901,000USD | 260,000USD | 435,000USD | 516,000USD | 235,000USD | 427,000USD | 253,000USD | 184,000USD |
| Common Stock | 1,000USD | 1,000USD | 1,000USD | 1,000USD | — | — | — | — |
| Retained Earnings | -163,195,000USD | -159,057,000USD | -155,054,000USD | -152,683,000USD | -150,291,000USD | -148,125,000USD | -146,356,000USD | -144,730,000USD |
| Total Liab | — | 950,000USD | 1,340,000USD | 1,666,000USD | 1,206,000USD | 1,270,000USD | 1,015,000USD | 919,000USD |
| Capital Stock | — | 1,000USD | 1,000USD | 1,000USD | 0USD | 0USD | 0USD | 0USD |
| Cash | — | 17,031,000USD | 21,031,000USD | 10,705,000USD | 10,775,000USD | 13,278,000USD | 5,382,000USD | 5,390,000USD |
| Cash And Short Term Investments | — | 17,031,000USD | 21,031,000USD | 10,705,000USD | 10,775,000USD | 13,278,000USD | 5,382,000USD | 5,390,000USD |
| Total Current Liabilities | — | 260,000USD | 435,000USD | 516,000USD | 1,206,000USD | 1,270,000USD | 1,015,000USD | 919,000USD |
| Net Debt | — | -17,031,000USD | -21,031,000USD | -10,705,000USD | -10,775,000USD | -13,278,000USD | -5,382,000USD | -5,390,000USD |
| Property Plant Equipment Gross | — | 10,000USD | 239,000USD | — | — | — | 308,000USD | 1,000USD |
| Common Stock Shares Outstanding | — | 11,617,250shares | 11,617,250shares | 5,468,584shares | 4,794,857shares | 4,307,264shares | 787,466shares | 990,033shares |
| Non Current Assets Total | — | 10,000USD | 11,000USD | 12,000USD | 7,000USD | 4,000USD | 2,000USD | 1,000USD |
| Non Current Liabilities Total | — | 690,000USD | 905,000USD | 1,150,000USD | 0USD | 0USD | 0USD | 0USD |
| Net Working Capital | — | 16,452,000USD | 20,136,000USD | 9,827,000USD | 10,088,000USD | 12,166,000USD | 4,721,000USD | 4,945,000USD |
| Unclassified Equity | — | 175,517,000USD | 175,199,000USD | 162,520,000USD | 160,386,000USD | 160,295,000USD | 151,079,000USD | 149,676,000USD |
| Unclassified Non Current Liabilities | — | — | — | 1,150,000USD | — | — | — | — |
| Other Current Liab | — | — | — | — | 971,000USD | 843,000USD | 762,000USD | 735,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 21,487,000USD | 5,738,000USD | 9,364,000USD | 12,814,000USD | 25,170,000USD | 15,739,000USD | 8,039,000USD | 15,322,000USD |
| Other Current Assets | 445,000USD | 354,000USD | 832,000USD | 665,000USD | 670,000USD | 920,000USD | 366,000USD | 271,000USD |
| Total Liab | 1,340,000USD | 1,015,000USD | 1,634,000USD | 1,974,000USD | 3,238,000USD | 2,722,000USD | 2,291,000USD | 1,744,000USD |
| Total Stockholder Equity | 20,147,000USD | 4,723,000USD | 7,730,000USD | 10,840,000USD | 21,932,000USD | 13,017,000USD | 5,748,000USD | 13,578,000USD |
| Common Stock | 1,000USD | — | — | — | 1,000USD | 1,000USD | 1,000USD | 2,000USD |
| Capital Stock | 1,000USD | 0USD | 0USD | 0USD | 1,000USD | 1,000USD | 1,000USD | 2,000USD |
| Retained Earnings | -155,054,000USD | -146,356,000USD | -139,206,000USD | -128,380,000USD | -116,900,000USD | -103,613,000USD | -94,819,000USD | -85,911,000USD |
| Cash | 21,031,000USD | 5,382,000USD | 8,490,000USD | 11,781,000USD | 24,057,000USD | 14,244,000USD | 6,934,000USD | 14,879,000USD |
| Cash And Short Term Investments | 21,031,000USD | 5,382,000USD | 8,490,000USD | 11,781,000USD | 24,057,000USD | 14,244,000USD | 6,934,000USD | 14,879,000USD |
| Total Current Assets | 21,476,000USD | 5,736,000USD | 9,322,000USD | 12,446,000USD | 24,727,000USD | 15,164,000USD | 7,300,000USD | 15,150,000USD |
| Total Current Liabilities | 435,000USD | 1,015,000USD | 1,634,000USD | 1,939,000USD | 3,068,000USD | 2,196,000USD | 1,880,000USD | 1,744,000USD |
| Net Debt | -21,031,000USD | -5,382,000USD | -8,455,000USD | -11,611,000USD | -23,762,000USD | -13,602,000USD | -6,416,000USD | -14,879,000USD |
| Accounts Payable | 435,000USD | 253,000USD | 657,000USD | 779,000USD | 283,000USD | 728,000USD | 809,000USD | 550,000USD |
| Property Plant Equipment Net | 11,000USD | 2,000USD | 39,000USD | 344,000USD | 416,000USD | 557,000USD | 721,000USD | 172,000USD |
| Property Plant Equipment Gross | 239,000USD | 308,000USD | 1,175,000USD | 344,000USD | 416,000USD | 557,000USD | 721,000USD | 172,000USD |
| Common Stock Shares Outstanding | 5,984,017shares | 787,466shares | 231,508shares | 126,159shares | 118,684shares | 42,432shares | 4,262shares | 1,184shares |
| Non Current Assets Total | 11,000USD | 2,000USD | 42,000USD | 368,000USD | 443,000USD | 575,000USD | 739,000USD | 172,000USD |
| Non Current Liabilities Total | 905,000USD | 0USD | 0USD | 35,000USD | 170,000USD | 526,000USD | 411,000USD | 0USD |
| Net Working Capital | 20,136,000USD | 4,721,000USD | 7,688,000USD | 10,507,000USD | 21,659,000USD | 12,968,000USD | 5,420,000USD | 13,406,000USD |
| Unclassified Equity | 175,199,000USD | 151,079,000USD | 146,936,000USD | 139,220,000USD | 138,830,000USD | 116,628,000USD | 101,613,000USD | 100,466,000USD |
| Other Current Liab | — | 762,000USD | 942,000USD | 1,025,000USD | 2,660,000USD | 1,352,000USD | 964,000USD | 1,194,000USD |
| Other Assets | — | — | 0USD | — | 27,000USD | 0USD | 18,000USD | — |
| Short Term Debt | — | — | 35,000USD | 135,000USD | 125,000USD | 116,000USD | 107,000USD | — |
| Short Long Term Debt Total | — | — | 35,000USD | 170,000USD | 295,000USD | 642,000USD | 518,000USD | — |
| Accumulated Other Comprehensive Income | — | — | 0USD | — | 0USD | — | -1,048,000USD | -981,000USD |
| Non Currrent Assets Other | — | — | 3,000USD | 24,000USD | 27,000USD | 18,000USD | 18,000USD | 172,000USD |
| Net Tangible Assets | — | — | — | — | 21,932,000USD | 13,017,000USD | 5,748,000USD | 13,578,000USD |
| Current Deferred Revenue | — | — | — | — | — | 1,248,000USD | 937,000USD | — |
| Long Term Debt | — | — | — | — | — | 231,000USD | — | — |
| Non Current Liabilities Other | — | — | — | — | — | 295,000USD | 411,000USD | — |
| Unclassified Current Liabilities | — | — | — | — | — | -1,248,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -4,003,000USD | -2,371,000USD | -2,392,000USD | -2,166,000USD | -1,769,000USD | -1,626,000USD | -1,524,000USD | -1,846,000USD |
| Depreciation | 1,000USD | 1,000USD | 2,000USD | 0USD | 0USD | 42,000USD | -42,000USD | 1,000USD |
| Stock Based Compensation | 318,000USD | 274,000USD | 113,000USD | 51,000USD | 43,000USD | 48,000USD | 52,000USD | 15,000USD |
| Other Non Cash Items | 315,000USD | 274,000USD | 113,000USD | — | — | -51,000USD | -1,018,000USD | 15,000USD |
| Change In Working Capital | -316,000USD | 17,000USD | 192,000USD | -425,000USD | 451,000USD | 216,000USD | -481,000USD | 53,000USD |
| Total Cash From Operating Activities | -4,003,000USD | -2,079,000USD | -2,085,000USD | -2,540,000USD | -1,275,000USD | -1,371,000USD | -1,953,000USD | -1,777,000USD |
| Capital Expenditures | 0USD | 0USD | -7,000USD | -3,000USD | -2,000USD | -1,000USD | 0USD | 0USD |
| Free Cash Flow | -4,003,000USD | -2,079,000USD | -2,092,000USD | -2,543,000USD | -1,277,000USD | -1,372,000USD | -1,953,000USD | -1,777,000USD |
| Total Cashflows From Investing Activities | 3,000USD | — | -7,000USD | -3,000USD | -2,000USD | 8,000USD | — | — |
| Total Cash From Financing Activities | 0USD | 12,405,000USD | 2,021,999USD | 40,000USD | 9,173,000USD | 1,355,000USD | 2,645,000USD | 0USD |
| Issuance Of Capital Stock | 0USD | 9,570,000USD | 1,852,000USD | 3,813,000USD | 6,493,000USD | 1,356,000USD | 2,646,000USD | 0USD |
| Change In Cash | -4,000,000USD | 10,326,000USD | -70,000USD | -2,503,000USD | 7,896,000USD | -8,000USD | 692,000USD | -1,777,000USD |
| Begin Period Cash Flow | 21,031,000USD | 10,705,000USD | 10,775,000USD | 13,278,000USD | 5,382,000USD | 5,390,000USD | 4,698,000USD | 6,475,000USD |
| End Period Cash Flow | 17,031,000USD | 21,031,000USD | 10,705,000USD | 10,775,000USD | 13,278,000USD | 5,382,000USD | 5,390,000USD | 4,698,000USD |
| Other Cashflows From Investing Activities | 3,000USD | — | — | — | — | 9,000USD | — | — |
| Unclassified Financing Cash Flow | — | 2,835,000USD | — | -3,773,000USD | — | 1,356,000USD | 2,404,000USD | — |
| Investments | — | — | -7,000USD | -3,000USD | -2,000USD | 8,000USD | 0USD | 0USD |
| Other Cashflows From Financing Activities | — | — | -30,000USD | — | 2,680,000USD | -1,000USD | 242,000USD | — |
| Sale Purchase Of Stock | — | — | — | — | — | 0USD | -1,000USD | 0USD |
| Unclassified Operating Cash Flow | — | — | — | — | — | — | 1,060,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -8,698,000USD | -7,150,000USD | -10,826,000USD | -11,480,000USD | -13,287,000USD | -8,794,000USD | -8,908,000USD | -7,360,000USD |
| Depreciation | 3,000USD | 35,000USD | 184,000USD | 193,000USD | 75,000USD | 72,000USD | 67,000USD | 81,000USD |
| Stock Based Compensation | 481,000USD | 147,000USD | 303,000USD | 414,000USD | 480,000USD | 136,000USD | 300,000USD | 282,000USD |
| Other Non Cash Items | -9,182,000USD | -6,000USD | 126,000USD | 496USD | 117,000USD | 111,000USD | 109,000USD | 405,000USD |
| Change In Working Capital | 235,000USD | -138,000USD | -536,000USD | -1,256,000USD | 990,000USD | -327,000USD | -213,000USD | -523,000USD |
| Total Cash From Operating Activities | -7,979,000USD | -7,112,000USD | -10,749,000USD | -12,129,000USD | -11,858,000USD | -8,802,000USD | -8,645,000USD | -7,520,000USD |
| Capital Expenditures | -12,000USD | -1,000USD | -5,000USD | -121,000USD | -51,000USD | -19,000USD | -72,000USD | -5,000USD |
| Free Cash Flow | -7,991,000USD | -7,113,000USD | -10,754,000USD | -12,250,000USD | -11,909,000USD | -8,821,000USD | -8,717,000USD | -7,525,000USD |
| Total Cashflows From Investing Activities | -12,000USD | 8,000USD | -5,000USD | -121,000USD | -51,000USD | -19,000USD | -72,000USD | -5,000USD |
| Total Cash From Financing Activities | 23,640,000USD | 3,996,000USD | 7,413,000USD | -26,000USD | 21,722,000USD | 16,131,000USD | 772,000USD | 18,823,000USD |
| Sale Purchase Of Stock | 0USD | -1,000USD | -11,000USD | -28USD | -1USD | -15,000USD | 1,000USD | 3,000USD |
| Issuance Of Capital Stock | 17,915,000USD | 4,002,000USD | 5,050,000USD | 2,000USD | 19,577,000USD | 12,088,000USD | 781,000USD | 18,718,000USD |
| Change In Cash | 15,649,000USD | -3,108,000USD | -3,341,000USD | -12,276,000USD | 9,813,000USD | 7,310,000USD | -7,945,000USD | 11,298,000USD |
| Begin Period Cash Flow | 5,382,000USD | 8,490,000USD | 11,831,000USD | 24,107,000USD | 14,294,000USD | 6,984,000USD | 14,929,000USD | 3,631,000USD |
| End Period Cash Flow | 21,031,000USD | 5,382,000USD | 8,490,000USD | 11,831,000USD | 24,107,000USD | 14,294,000USD | 6,984,000USD | 14,929,000USD |
| Other Cashflows From Financing Activities | -30,000USD | -5,000USD | -28,000USD | -26,000USD | 2,145,000USD | 8,172,000USD | -3,000USD | 102,000USD |
| Unclassified Operating Cash Flow | 9,182,000USD | — | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | 23,670,000USD | 4,002,000USD | 7,452,000USD | — | 19,577,001USD | 11,857,000USD | — | 18,724,000USD |
| Investments | — | 8,000USD | -5,000USD | -121,000USD | -51,000USD | -19,000USD | -72,000USD | -5,000USD |
| Other Cashflows From Investing Activities | — | 9,000USD | — | — | — | — | — | — |
| Change To Liabilities | — | — | — | — | -445,000USD | -81,000USD | 2,000USD | -521,000USD |
| Net Borrowings | — | — | — | — | 0USD | 204,000USD | -6,000USD | -6,000USD |
| Dividends Paid | — | — | — | — | — | -4,087,000USD | -1,000USD | — |
| Cash And Cash Equivalents Changes | — | — | — | — | — | 7,310,000USD | -7,945,000USD | 11,298,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.